Clinical Trials and the Independence of Investigators: A Novel Method for the Conduct of Pharmaceutical Company-Funded Clinical Drug Trials Which Ensures Investigator Independence

By Beran Roy G.   Ainley Laetitia A.E.   Beran Maureen E.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 5-6, 2005-01 ,pp. : 309-316

Adis International

Access to resources Recommend Favorite

Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study

By Keinonen T.   Keränen T.   Klaukka T.   Saano V.   Ylitalo P.   Enlund H.  

Pharmacy World and Science, Vol. 25, Iss. 6, 2003-12 ,pp. : 251-259

Springer Publishing Company

Access to resources Recommend Favorite

Investigator Attitudes towards Participation in Contract Research Organization-Managed Clinical Studies: A Survey of US Investigators

By Glass Harold E.  

Pharmaceutical Medicine, Vol. 23, Iss. 2, 2009-04 ,pp. : 85-90

Adis International

Access to resources Recommend Favorite

Cancer vaccines entering Phase III clinical trials

By Durrant LG   Spendlove I  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH): Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or Knee Replacement Surgery

By Watkins Paul B.  

Drug Safety, Vol. 34, Iss. 3, 2011-03 ,pp. : 243-252

Adis International

Access to resources Recommend Favorite